APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dutasteride Drug Industry Growth and Trends Forecast to 2032

28 December 2025116 pages

Choose your research edition.

Industry ResearchDutasteride Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dutasteride Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dutasteride Drug include GSK, Acella Pharmaceuticals, Amneal Pharmaceuticals, Ascent Pharmaceuticals, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Endo and Strides Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dutasteride Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dutasteride Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dutasteride Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dutasteride Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dutasteride Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dutasteride Drug Market by Company

GSK

Acella Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Aurobindo Pharma

Barr Pharmaceuticals

Chartwell

Endo

Strides Pharma

Waylis Therapeutics

Zydus

Chengdu Suncadia Medicine

Jiangsu Wangao Pharmaceutical

Qilu Pharmaceutical

Humanwell Puracap

Sichuan Gowell Pharmaceutical

Dutasteride Drug Segment by Type

Single Drug

Combination Preparation

Dutasteride Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Dutasteride Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dutasteride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Drug Table 2. Major Company of Combination Preparation Table 3. Global Dutasteride Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Dutasteride Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dutasteride Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Dutasteride Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Dutasteride Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dutasteride Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dutasteride Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Dutasteride Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Dutasteride Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Dutasteride Drug Industry Trends Table 25. Dutasteride Drug Industry Drivers Table 26. Dutasteride Drug Industry Opportunities and Challenges Table 27. Dutasteride Drug Industry Restraints Table 28. Global Dutasteride Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dutasteride Drug Revenue Market Share by Company (2021-2026) Table 30. Global Dutasteride Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Dutasteride Drug Sales Share by Company (2021-2026) Table 32. Global Dutasteride Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Dutasteride Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dutasteride Drug Major Company Production Sites and Headquarters Table 35. Global Dutasteride Drug Company, Product Type & Application Table 36. Global Dutasteride Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dutasteride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dutasteride Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dutasteride Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Dutasteride Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dutasteride Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dutasteride Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Dutasteride Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Dutasteride Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dutasteride Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dutasteride Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Dutasteride Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Dutasteride Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dutasteride Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Dutasteride Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Dutasteride Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dutasteride Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dutasteride Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Dutasteride Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Dutasteride Drug Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Dutasteride Drug Product Portfolio Table 75. GSK Recent Development Table 76. Acella Pharmaceuticals Company Information Table 77. Acella Pharmaceuticals Business Overview Table 78. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Acella Pharmaceuticals Dutasteride Drug Product Portfolio Table 80. Acella Pharmaceuticals Recent Development Table 81. Amneal Pharmaceuticals Company Information Table 82. Amneal Pharmaceuticals Business Overview Table 83. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Amneal Pharmaceuticals Dutasteride Drug Product Portfolio Table 85. Amneal Pharmaceuticals Recent Development Table 86. Ascent Pharmaceuticals Company Information Table 87. Ascent Pharmaceuticals Business Overview Table 88. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ascent Pharmaceuticals Dutasteride Drug Product Portfolio Table 90. Ascent Pharmaceuticals Recent Development Table 91. Aurobindo Pharma Company Information Table 92. Aurobindo Pharma Business Overview Table 93. Aurobindo Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Aurobindo Pharma Dutasteride Drug Product Portfolio Table 95. Aurobindo Pharma Recent Development Table 96. Barr Pharmaceuticals Company Information Table 97. Barr Pharmaceuticals Business Overview Table 98. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Barr Pharmaceuticals Dutasteride Drug Product Portfolio Table 100. Barr Pharmaceuticals Recent Development Table 101. Chartwell Company Information Table 102. Chartwell Business Overview Table 103. Chartwell Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chartwell Dutasteride Drug Product Portfolio Table 105. Chartwell Recent Development Table 106. Endo Company Information Table 107. Endo Business Overview Table 108. Endo Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Endo Dutasteride Drug Product Portfolio Table 110. Endo Recent Development Table 111. Strides Pharma Company Information Table 112. Strides Pharma Business Overview Table 113. Strides Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Strides Pharma Dutasteride Drug Product Portfolio Table 115. Strides Pharma Recent Development Table 116. Waylis Therapeutics Company Information Table 117. Waylis Therapeutics Business Overview Table 118. Waylis Therapeutics Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Waylis Therapeutics Dutasteride Drug Product Portfolio Table 120. Waylis Therapeutics Recent Development Table 121. Zydus Company Information Table 122. Zydus Business Overview Table 123. Zydus Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zydus Dutasteride Drug Product Portfolio Table 125. Zydus Recent Development Table 126. Chengdu Suncadia Medicine Company Information Table 127. Chengdu Suncadia Medicine Business Overview Table 128. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio Table 130. Chengdu Suncadia Medicine Recent Development Table 131. Jiangsu Wangao Pharmaceutical Company Information Table 132. Jiangsu Wangao Pharmaceutical Business Overview Table 133. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio Table 135. Jiangsu Wangao Pharmaceutical Recent Development Table 136. Qilu Pharmaceutical Company Information Table 137. Qilu Pharmaceutical Business Overview Table 138. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Qilu Pharmaceutical Dutasteride Drug Product Portfolio Table 140. Qilu Pharmaceutical Recent Development Table 141. Humanwell Puracap Company Information Table 142. Humanwell Puracap Business Overview Table 143. Humanwell Puracap Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Humanwell Puracap Dutasteride Drug Product Portfolio Table 145. Humanwell Puracap Recent Development Table 146. Sichuan Gowell Pharmaceutical Company Information Table 147. Sichuan Gowell Pharmaceutical Business Overview Table 148. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio Table 150. Sichuan Gowell Pharmaceutical Recent Development Table 151. North America Dutasteride Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 153. North America Dutasteride Drug Sales Market Share by Country (2021-2026) Table 154. North America Dutasteride Drug Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America Dutasteride Drug Sales Market Share Forecast by Country (2027-2032) Table 156. North America Dutasteride Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Dutasteride Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Dutasteride Drug Market Share by Country (2021-2026) Table 159. North America Dutasteride Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Dutasteride Drug Market Share Forecast by Country (2027-2032) Table 161. Europe Dutasteride Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 163. Europe Dutasteride Drug Sales Market Share by Country (2021-2026) Table 164. Europe Dutasteride Drug Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe Dutasteride Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Dutasteride Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Dutasteride Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Dutasteride Drug Market Share by Country (2021-2026) Table 169. Europe Dutasteride Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Dutasteride Drug Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Dutasteride Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific Dutasteride Drug Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Dutasteride Drug Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific Dutasteride Drug Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Dutasteride Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Dutasteride Drug Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Dutasteride Drug Market Share by Country (2021-2026) Table 179. Asia-Pacific Dutasteride Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Dutasteride Drug Market Share Forecast by Country (2027-2032) Table 181. Latin America Dutasteride Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 183. Latin America Dutasteride Drug Sales Market Share by Country (2021-2026) Table 184. Latin America Dutasteride Drug Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America Dutasteride Drug Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Dutasteride Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Dutasteride Drug Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Dutasteride Drug Market Share by Country (2021-2026) Table 189. Latin America Dutasteride Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Dutasteride Drug Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Dutasteride Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa Dutasteride Drug Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Dutasteride Drug Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa Dutasteride Drug Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Dutasteride Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Dutasteride Drug Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Dutasteride Drug Market Share by Country (2021-2026) Table 199. Middle East and Africa Dutasteride Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Dutasteride Drug Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Dutasteride Drug Distributors List Table 204. Dutasteride Drug Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Dutasteride Drug Image Figure 2. Global Dutasteride Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Dutasteride Drug Sales (2021-2032) & (K Units) Figure 5. Single Drug Image Figure 6. Global Single Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Preparation Image Figure 8. Global Combination Preparation Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Dutasteride Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dutasteride Drug Market Share by Type 2025 VS 2032 Figure 11. North America Dutasteride Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Dutasteride Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Dutasteride Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dutasteride Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dutasteride Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dutasteride Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dutasteride Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dutasteride Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dutasteride Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dutasteride Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dutasteride Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacy Image Figure 28. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Dutasteride Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dutasteride Drug Market Share by Application 2025 VS 2032 Figure 31. North America Dutasteride Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Dutasteride Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Dutasteride Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dutasteride Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dutasteride Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dutasteride Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dutasteride Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dutasteride Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dutasteride Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dutasteride Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Dutasteride Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dutasteride Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Dutasteride Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dutasteride Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Dutasteride Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dutasteride Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Dutasteride Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dutasteride Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Dutasteride Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dutasteride Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dutasteride Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dutasteride Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • GSK
  • Acella Pharmaceuticals
  • Amneal Pharmaceuticals
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Barr Pharmaceuticals
  • Chartwell
  • Endo
  • Strides Pharma
  • Waylis Therapeutics
  • Zydus
  • Chengdu Suncadia Medicine
  • Jiangsu Wangao Pharmaceutical
  • Qilu Pharmaceutical
  • Humanwell Puracap
  • Sichuan Gowell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dutasteride Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dutasteride Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dutasteride Drug Market by Type
  6. 1.3.1 Single Drug
  7. 1.3.2 Combination Preparation
  8. 1.4 Global Dutasteride Drug Market Size by Type
  9. 1.4.1 Global Dutasteride Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dutasteride Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dutasteride Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dutasteride Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dutasteride Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dutasteride Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dutasteride Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dutasteride Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dutasteride Drug Industry Trends
  2. 2.2 Dutasteride Drug Industry Drivers
  3. 2.3 Dutasteride Drug Industry Opportunities and Challenges
  4. 2.4 Dutasteride Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dutasteride Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Dutasteride Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Dutasteride Drug Price (2021-2026)
  4. 3.4 Global Dutasteride Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dutasteride Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Dutasteride Drug Company, Product Type & Application
  7. 3.7 Global Dutasteride Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dutasteride Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dutasteride Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dutasteride Drug Tier 1, Tier 2, and Tier 3
4 Dutasteride Drug Regional Status and Outlook
  1. 4.1 Global Dutasteride Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dutasteride Drug Historic Market Size by Region
  3. 4.2.1 Global Dutasteride Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dutasteride Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dutasteride Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dutasteride Drug Forecasted Market Size by Region
  7. 4.3.1 Global Dutasteride Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dutasteride Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dutasteride Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dutasteride Drug by Application
  1. 5.1 Dutasteride Drug Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Dutasteride Drug Market Size by Application
  6. 5.2.1 Global Dutasteride Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dutasteride Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dutasteride Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dutasteride Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dutasteride Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dutasteride Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dutasteride Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dutasteride Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Dutasteride Drug Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Acella Pharmaceuticals
  8. 6.2.1 Acella Pharmaceuticals Company Information
  9. 6.2.2 Acella Pharmaceuticals Business Overview
  10. 6.2.3 Acella Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
  12. 6.2.5 Acella Pharmaceuticals Recent Developments
  13. 6.3 Amneal Pharmaceuticals
  14. 6.3.1 Amneal Pharmaceuticals Company Information
  15. 6.3.2 Amneal Pharmaceuticals Business Overview
  16. 6.3.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
  18. 6.3.5 Amneal Pharmaceuticals Recent Developments
  19. 6.4 Ascent Pharmaceuticals
  20. 6.4.1 Ascent Pharmaceuticals Company Information
  21. 6.4.2 Ascent Pharmaceuticals Business Overview
  22. 6.4.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
  24. 6.4.5 Ascent Pharmaceuticals Recent Developments
  25. 6.5 Aurobindo Pharma
  26. 6.5.1 Aurobindo Pharma Company Information
  27. 6.5.2 Aurobindo Pharma Business Overview
  28. 6.5.3 Aurobindo Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
  30. 6.5.5 Aurobindo Pharma Recent Developments
  31. 6.6 Barr Pharmaceuticals
  32. 6.6.1 Barr Pharmaceuticals Company Information
  33. 6.6.2 Barr Pharmaceuticals Business Overview
  34. 6.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
  36. 6.6.5 Barr Pharmaceuticals Recent Developments
  37. 6.7 Chartwell
  38. 6.7.1 Chartwell Company Information
  39. 6.7.2 Chartwell Business Overview
  40. 6.7.3 Chartwell Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chartwell Dutasteride Drug Product Portfolio
  42. 6.7.5 Chartwell Recent Developments
  43. 6.8 Endo
  44. 6.8.1 Endo Company Information
  45. 6.8.2 Endo Business Overview
  46. 6.8.3 Endo Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Endo Dutasteride Drug Product Portfolio
  48. 6.8.5 Endo Recent Developments
  49. 6.9 Strides Pharma
  50. 6.9.1 Strides Pharma Company Information
  51. 6.9.2 Strides Pharma Business Overview
  52. 6.9.3 Strides Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Strides Pharma Dutasteride Drug Product Portfolio
  54. 6.9.5 Strides Pharma Recent Developments
  55. 6.10 Waylis Therapeutics
  56. 6.10.1 Waylis Therapeutics Company Information
  57. 6.10.2 Waylis Therapeutics Business Overview
  58. 6.10.3 Waylis Therapeutics Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
  60. 6.10.5 Waylis Therapeutics Recent Developments
  61. 6.11 Zydus
  62. 6.11.1 Zydus Company Information
  63. 6.11.2 Zydus Business Overview
  64. 6.11.3 Zydus Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zydus Dutasteride Drug Product Portfolio
  66. 6.11.5 Zydus Recent Developments
  67. 6.12 Chengdu Suncadia Medicine
  68. 6.12.1 Chengdu Suncadia Medicine Company Information
  69. 6.12.2 Chengdu Suncadia Medicine Business Overview
  70. 6.12.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
  72. 6.12.5 Chengdu Suncadia Medicine Recent Developments
  73. 6.13 Jiangsu Wangao Pharmaceutical
  74. 6.13.1 Jiangsu Wangao Pharmaceutical Company Information
  75. 6.13.2 Jiangsu Wangao Pharmaceutical Business Overview
  76. 6.13.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
  78. 6.13.5 Jiangsu Wangao Pharmaceutical Recent Developments
  79. 6.14 Qilu Pharmaceutical
  80. 6.14.1 Qilu Pharmaceutical Company Information
  81. 6.14.2 Qilu Pharmaceutical Business Overview
  82. 6.14.3 Qilu Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
  84. 6.14.5 Qilu Pharmaceutical Recent Developments
  85. 6.15 Humanwell Puracap
  86. 6.15.1 Humanwell Puracap Company Information
  87. 6.15.2 Humanwell Puracap Business Overview
  88. 6.15.3 Humanwell Puracap Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Humanwell Puracap Dutasteride Drug Product Portfolio
  90. 6.15.5 Humanwell Puracap Recent Developments
  91. 6.16 Sichuan Gowell Pharmaceutical
  92. 6.16.1 Sichuan Gowell Pharmaceutical Company Information
  93. 6.16.2 Sichuan Gowell Pharmaceutical Business Overview
  94. 6.16.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
  96. 6.16.5 Sichuan Gowell Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Dutasteride Drug Sales by Country
  2. 7.1.1 North America Dutasteride Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dutasteride Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Dutasteride Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dutasteride Drug Market Size by Country
  6. 7.2.1 North America Dutasteride Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dutasteride Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Dutasteride Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dutasteride Drug Sales by Country
  2. 8.1.1 Europe Dutasteride Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dutasteride Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Dutasteride Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dutasteride Drug Market Size by Country
  6. 8.2.1 Europe Dutasteride Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dutasteride Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dutasteride Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dutasteride Drug Sales by Country
  2. 9.1.1 Asia-Pacific Dutasteride Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dutasteride Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dutasteride Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dutasteride Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Dutasteride Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dutasteride Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dutasteride Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dutasteride Drug Sales by Country
  2. 10.1.1 South America Dutasteride Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dutasteride Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Dutasteride Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dutasteride Drug Market Size by Country
  6. 10.2.1 South America Dutasteride Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dutasteride Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Dutasteride Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dutasteride Drug Sales by Country
  2. 11.1.1 Middle East and Africa Dutasteride Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dutasteride Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dutasteride Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dutasteride Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Dutasteride Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dutasteride Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dutasteride Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dutasteride Drug Value Chain Analysis
  2. 12.1.1 Dutasteride Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dutasteride Drug Production Mode & Process
  7. 12.2 Dutasteride Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dutasteride Drug Distributors
  10. 12.2.3 Dutasteride Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst